What is driving the CSL share price higher today?

CSL shares are having a good day…

| More on:
A doctor appears shocked as he looks through binoculars on a blue background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • CSL shares are on form on Wednesday
  • There have been a couple of catalysts for this solid gain
  • CSL's shares have been boosted by legal news and a couple of broker notes

The CSL Limited (ASX: CSL) share price has been a positive performer on Wednesday.

In afternoon trade, the biotherapeutics giant's shares are up 2.5% to $277.12.

This compares favourably to a 0.1% decline by the ASX 200 index.

Why is the CSL share price rising today?

There have been a couple of catalysts for the rise in the CSL share price today.

One has been a legal breakthrough in the United States and the other is the release of a couple of bullish broker notes.

In respect to the former, according to the SMH, CSL and Grifols now have a right to appeal the banning of Mexican citizens from crossing the border to donate plasma. Its previous appeal to have the ban overturned was rejected, but that rejection was found to have been improperly dismissed.

And while there is no guarantee that the two parties will be able to successfully overturn the decision, it is a step in the right direction.

What else?

Also giving the CSL share price a boost today has been the release of broker notes out of Jefferies and Morgan Stanley.

Both brokers have retained the equivalent of buy ratings with $315 and $310 price targets, respectively.

Jefferies highlights that CSL's impending shift to a new plasma collection system could be a big boost to sales and margins over the coming years. It commented: "We believe CSL has this relationship with Terumo exclusively for 4-5 years, and so these benefits are likely to be sustainable."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »